Biocryst Pharmaceuticals reported $26.32M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Chemocentryx CCXI:US $ 19.7M 3.44M
Chugai Pharma 4519:JP 23.08B 3.29B
Daiichi Sankyo 4568:JP 79.12B 24.69B
Enanta Pharmaceuticals ENTA:US $ 8.48M 151K
Gilead Sciences GILD:US $ 1.34B 297M
GlaxoSmithKline GSK:LN 2.5B 183M
Glaxosmithkline GSK:US 2.5B 183M
Intra Cellular Therapies ITCI:US $ 69.85M 17.27M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Karyopharm Therapeutics KPTI:US $ 36.53M 1.12M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novavax NVAX:US $ 73.16M 9.97M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
YTE INCY:US $ 168.86M 15.06M
Zogenix ZGNX:US $ 33.88M 2.61M